BioArctic AB
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-08-26
Max Staff
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Max Staff
Max Staff is recorded as Analyst at Goldman Sachs. Max Staff has spoken on 1 earnings call across 1 company, most recently for BioArctic AB on August 26, 2026. The companies whose calls Max Staff spoke on are classified in the Healthcare sector.
Max Staff on recent calls
“So in your Phase 2a study, did you see any efficacy signal? And when should we expect the results from the Phase 2b study? Second question, how will you prioritize between extantimab and BAN-38?”
Affiliation history
-
Goldman Sachs
Analyst
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
Interim Report Q2 2026
BioArctic AB